ArticleProceedings of the National Academy of Sciences of the United States of America2011

Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.

Ahmet Arac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.